Online consultations with MCSC doctors n. a. A. S. Loginov

Chronic liver diseases: diagnosis, treatment, prevention (Electronic educational course, 36 hours)

Category of trainees: doctors-specialists in the areas of training: "Gastroenterology", " General medical practice (family medicine)", "Therapy", "Medical business".

The complexity of the program: 36 academic hours.

Form of training: distance learning by means of an electronic educational environment with the use of interactive communication technologies.

Relevance.

According to the World Health Organization, in recent decades, the world has seen an increase in the number of chronic liver diseases (CKD) of various etiologies and related deaths.

Currently, there are about 257 million patients with chronic hepatitis B and 71 million patients with chronic hepatitis C. The mortality rate from viral hepatitis is comparable to that from tuberculosis and exceeds that from HIV infection. To diagnose viral hepatitis and determine the tactics of patient management, it is necessary to correctly use laboratory and instrumental research methods. Modern antiviral therapy can effectively and safely suppress the replication of the hepatitis B virus and achieve the eradication of the hepatitis C virus, which significantly improves the prognosis of patients.

About 6% of all deaths in the world are associated with alcohol abuse. Effective diagnosis and treatment of alcoholic liver disease is an important public health issue.

In recent years , non-alcoholic fatty liver disease (NAFLD) has taken a leading position among CKD, replacing viral and alcoholic lesions. In Europe and the United States, its prevalence in the adult population is 25-35%. Due to the important clinical significance of NAFLD due not only to its wide prevalence, but also to the likelihood of progression of fibrosis (with the possible formation of cirrhosis of the liver and hepatocellular carcinoma), approaches to the diagnosis and treatment of this disease continue to improve.

Autoimmune liver diseases (AIPD) includeautoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis. There is an increase in the number of AIZP among women and men in all age groups. Timely and accurate diagnosis of AIZP, as well as the choice of effective therapy for patients of this category, have many nuances.

Diseases characterized by excessive accumulation of copper or iron in organs and tissues may have a latent clinical course for a long time. Early diagnosis and competent therapy of hereditary or secondary hemochromatosis and Wilson's disease can prevent their progression and severe outcomes.

Despite the significant advances made in recent years , the prevention of CKD, its early diagnosis and effective therapy remains a complex task that requires a doctor's deep knowledge in this area.

As part of the course, students:

  • The issues of epidemiology, etiology and pathogenesis of the main chronic liver diseases will be considered;
  • They will analyze the differential diagnosis of jaundice of various origins;
  • They will study modern approaches to the diagnosis, treatment and prevention of chronic viral hepatitis, autoimmune liver diseases, alcoholic and medicinal lesions, non-alcoholic fatty liver disease and accumulation diseases (hemochromatosis, Wilson's disease);
  • They will get acquainted with the peculiarities of management of patients with decompensated cirrhosis of the liver;
  • They will learn to correctly assess the potential risk of drug interactions;

Speakers of the professional development cycle:

  1. Vinnitskaya Elena Vladimirovna, Head of the Department of Hepatology, MD.;
  2. Podymova Svetlana Dmitrievna, Leading Researcher, MD.;
  3. Yulia G. Sandler, Senior Researcher, PhD;
  4. Batskikh Sergey Nikolaevich, Senior Researcher, Candidate of Medical Sciences;
  5. Keyyan Vitaliya Aleksandrovna, Research Associate;
  6. Sbikina Evgeniya Sergeevna, Junior Researcher;

Course program

Sign up for the course and complete the training

GBUZ Moscow Clinical Scientific Center named after Loginov MHD Social network presence: